Reaction
Ileal Stenosis reporting signals
As of the last recalculation, Ileal Stenosis appears in 1,755 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is AZATHIOPRINE (PRR 43.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Azathioprine | 272 | 43.1 | 43.3 |
| Vedolizumab | 251 | 40.2 | 40.3 |
| Adalimumab-Fkjp | 127 | 35.0 | 35.1 |
| Adalimumab-Aaty | 125 | 33.6 | 33.7 |
| Adalimumab-Adaz | 137 | 33.3 | 33.4 |
| Mercaptopurine | 40 | 28.0 | 28.0 |
| Infliximab | 374 | 25.5 | 25.6 |
| Adalimumab | 813 | 24.5 | 24.6 |
| Cholestyramine | 22 | 21.8 | 21.9 |
| Infliximab-Dyyb | 50 | 20.9 | 20.9 |
| Mesalamine | 91 | 20.2 | 20.2 |
| Budesonide | 95 | 20.2 | 20.2 |
| Ustekinumab | 155 | 19.6 | 19.6 |
| Encorafenib | 10 | 12.0 | 12.1 |
| Risankizumab-Rzaa | 65 | 9.8 | 9.8 |
| Isotretinoin | 36 | 8.8 | 8.8 |
| Upadacitinib | 48 | 7.2 | 7.2 |
| Bleomycin Sulfate | 5 | 5.8 | 5.8 |